Search Results for: prostate cancer

Different prostate-specific antigen (PSA) assays give different results on the same blood sample, according to German researchers. This, they say, is an obstacle to recommending uniform PSA limits for prostate biopsies.

The prostate specific antigen (PSA) level and the level of pathologist expertise are key factors in determining whether the Gleason score of a given prostate cancer should be upgraded to indicate higher grade disease, new research suggest.

LabCorp has entered into a license agreement with Veridex LLC to commercialize nucleic acid testing technology for detecting the presence of methylated GST-Pi, a key tissue marker in prostate cancer.